Abstract

The diversity of the naïve T cell repertoire drives the replenishment potential and capacity of memory T cells to respond to immune challenges. Attrition of the immune system is associated with an increased prevalence of pathologies in aged individuals, but whether stem cell memory T lymphocytes (TSCM) contribute to such attrition is still unclear. Using single cells RNA sequencing and high-dimensional flow cytometry, we demonstrate that TSCM heterogeneity results from differential engagement of Wnt signaling. In humans, aging is associated with the coupled loss of Wnt/β-catenin signature in CD4 TSCM and systemic increase in the levels of Dickkopf-related protein 1, a natural inhibitor of the Wnt/β-catenin pathway. Functional assays support recent thymic emigrants as the precursors of CD4 TSCM. Our data thus hint that reversing TSCM defects by metabolic targeting of the Wnt/β-catenin pathway may be a viable approach to restore and preserve immune homeostasis in the context of immunological history.

Aging is associated with immune attrition that may impact the effectiveness of the immune system to protect the host from pathogens. Here the authors show that immune aging is associated with alterations in the Wnt/β-catenin signaling and reduced stem cell memory T lymphocytes, hinting the Wnt/β-catenin pathway as a potential therapy target.

Details

Title
Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway
Author
Hassen, Kared 1   VIAFID ORCID Logo  ; Tan, Shu Wen 1 ; Lau Mai Chan 1 ; Chevrier, Marion 1   VIAFID ORCID Logo  ; Tan, Crystal 1 ; Wilson, How 1 ; Wong, Glenn 1 ; Strickland, Marie 2   VIAFID ORCID Logo  ; Malleret Benoit 3   VIAFID ORCID Logo  ; Amoah, Amanda 4 ; Pilipow Karolina 5 ; Zanon, Veronica 5 ; Govern, Naomi Mc 1 ; Lum, Josephine 1 ; Chen Jin Miao 1 ; Lee, Bernett 1 ; Carolina, Florian Maria 4 ; Geiger Hartmut 6 ; Ginhoux Florent 1   VIAFID ORCID Logo  ; Ruiz-Mateos, Ezequiel 7 ; Fulop Tamas 8 ; Rajasuriar Reena 9 ; Kamarulzaman Adeeba 10 ; Ng, Tze Pin 11 ; Lugli Enrico 12   VIAFID ORCID Logo  ; Anis, Larbi 13 

 Agency for Science Technology and Research (A*STAR), Singapore Immunology Network (SIgN), Biopolis, Republic of Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221) 
 Agency for Science Technology and Research (A*STAR), Singapore Immunology Network (SIgN), Biopolis, Republic of Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); University of Southampton, Clinical and Experimental Sciences, Faculty of Medicine, Southampton, UK (GRID:grid.5491.9) (ISNI:0000 0004 1936 9297) 
 Agency for Science Technology and Research (A*STAR), Singapore Immunology Network (SIgN), Biopolis, Republic of Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, Singapore, Republic of Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
 University of Ulm, Institute of Molecular Medicine, Ulm, Germany (GRID:grid.6582.9) (ISNI:0000 0004 1936 9748) 
 Laboratory of Translational Immunology (LTI), Humanitas Clinical and Research Center, Rozzano, Italy (GRID:grid.6582.9) 
 University of Ulm, Institute of Molecular Medicine, Ulm, Germany (GRID:grid.6582.9) (ISNI:0000 0004 1936 9748); Experimental Hematology and Cancer Biology, CCHMC, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099) 
 University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229) 
 University of Sherbrooke, Department of Medicine, Faculty of Medicine, Sherbrooke, Canada (GRID:grid.86715.3d) (ISNI:0000 0000 9064 6198) 
 University of Malaya, Centre of Excellence for Research in AIDS (CERiA), Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949); University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); University of Malaya, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949) 
10  University of Malaya, Centre of Excellence for Research in AIDS (CERiA), Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949); University of Malaya, Faculty of Medicine, Kuala Lumpur, Malaysia (GRID:grid.10347.31) (ISNI:0000 0001 2308 5949) 
11  National University of Singapore, Gerontology Research Programme and Department of Psychological Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
12  Laboratory of Translational Immunology (LTI), Humanitas Clinical and Research Center, Rozzano, Italy (GRID:grid.4280.e) 
13  Agency for Science Technology and Research (A*STAR), Singapore Immunology Network (SIgN), Biopolis, Republic of Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, Singapore, Republic of Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); University of Sherbrooke, Department of Medicine, Faculty of Medicine, Sherbrooke, Canada (GRID:grid.86715.3d) (ISNI:0000 0000 9064 6198) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2352999005
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.